Adipocytokines in Anorexia Nervosa: a Review Focusing on Leptin and Adiponectin

S. M. Brichard; M. L. Delporte; M. Lambert

doi:10.1055/s-2003-41353

Hormone and Metabolic Research, Table of Contents

Horm Metab Res 2003; 35(6): 337-342
DOI: 10.1055/s-2003-41353

Review

Adipocytokines in Anorexia Nervosa: a Review Focusing on Leptin and Adiponectin

S. M. Brichard ¹ , M. L. Delporte ¹ , M. Lambert ²

¹ Endocrinology and Metabolism Unit
² Division of General Internal Medicine, Saint-Luc University Hospital, University of Louvain, Medical School, Brussels, Belgium

Abstract

Adipose tissue secretes a large number of physiologically active peptides that often share structural properties with cytokines, and are therefore collectively referred to as ”adipocytokines”. Some of these are almost exclusively secreted by adipose tissue. Leptin, adiponectin and resistin are specific fat-derived hormones that affect fuel homeostasis and insulin action, and may also be involved in hematopoiesis and immune functions. Anorexia nervosa is characterized by chronic self-starvation and severe weight loss, mainly at the expense of adipose tissue. Starvation-induced depletion of fat stores is accompanied by alterations of circulating adipocytokines. Plasma leptin and likely resistin levels are decreased in anorectic patients, while plasma adiponectin levels are increased. These alterations may have potential repercussions in the pathophysiology of anorexia nervosa. Thus, low leptin and high adiponectin may separately or in concert contribute to altered hematopoiesis and immunity, enhanced insulin sensitivity, neuroendocrine disturbances or osteopenia in anorexia nervosa.

Key words

Leptin - Resistin - Adiponectin - Starvation - Insulin Action - Fuel Homeostasis

Full Text

References

1 Lambert M, Lion L, Vanderdonckt J, Maiter D. Anormalies endocriniennes de l'anorexie mentale. Rev Franç Endocrinol Clin. 1997; 38 569-577
2 Stoving R K, Hangaard J, Hansen-Nord M, Hagen C. A review of endocrine changes in anorexia nervosa. J Psychiatr Res. 1999; 33 139-152
3 Rubin R T, Kaye W H. Anorexia nervosa and others eating disorders. In: Endocrinology. DeGroot LJ and Jameson JL (Eds) Philadelphia; W. B. Saunders Company 2001: 631-641
4 Lambert M, Hubert C, Depresseux G, Vande B B, Thissen J P, Nagant d D. Hematological changes in anorexia nervosa are correlated with total body fat mass depletion. Int J Eat Disord. 1997; 21 329-334
5 Devuyst O, Lambert M, Rodhain J, Lefebvre C, Coche E. Haematological changes and infectious complications in anorexia nervosa: a case-control study. Q J Med. 1993; 86 791-799
6 Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab. 2002; 87 2883-2891
7 Trayhurn P, Beattie J H. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc. 2001; 60 329-339
8 Ravussin E, Smith S R. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci. 2002; 967 363-378
9 Caro J F, Sinha M K, Kolaczynski J W, Zhang P L, Considine R V. Leptin: the tale of an obesity gene. Diabetes. 1996; 45 1455-1462
10 Chan J L, Bluher S, Yiannakouris N, Suchard M A, Kratzsch J, Mantzoros C S. Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans. Diabetes. 2002; 51 2105-2112
11 Grinspoon S, Gulick T, Askari H, Landt M, Lee K, Anderson E, Ma Z, Vignati L, Bowsher R, Herzog D, Klibanski A. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab. 1996; 81 3861-3863
12 Mantzoros C, Flier J S, Lesem M D, Brewerton T D, Jimerson D C. Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain. J Clin Endocrinol Metab. 1997; 82 1845-1851
13 Ferron F, Considine R V, Peino R, Lado I G, Dieguez C, Casanueva F F. Serum leptin concentrations in patients with anorexia nervosa, bulimia nervosa and non-specific eating disorders correlate with the body mass index but are independent of the respective disease. Clin Endocrinol. 1997; 46 289-293
14 Balligand J L, Brichard S M, Brichard V, Desager J P, Lambert M. Hypoleptinemia in patients with anorexia nervosa: loss of circadian rhythm and unresponsiveness to short-term refeeding. Eur J Endocrinol. 1998; 138 415-420
15 Kratzsh J, Lammert A, Bottner A, Seidel B, Mueller G, Thiery J, Hedebrand J, Kiess W. Circulating soluble leptin receptor and free leptin index during childhood, puberty, and adolescence. J Clin Endocrinol Metab. 2002; 87 4587-4594
16 Stoving R K, Vinten J, Handberg A, Ebbesen E N, Hangaard J, Hansen-Nord M, Kristiansen J, Hagen C. Diurnal variation of the serum leptin concentration in patients with anorexia nervosa. Clin Endocrinol. 1998; 48 761-768
17 Laughlin G A, Yen S S. Hypoleptinemia in women athletes: absence of a diurnal rhythm with amenorrrhea. J Clin Endocrinol Metab. 1997; 82 318-321
18 Casanueva F F, Dieguez C, Popovic V, Peino R, Considine R V, Caro J F. Serum immunoreactive leptin concentrations in patients with anorexia nervosa before and after partial weight recovery. Biochem Mol Med. 1997; 60 116-120
19 Hebebrand J, Blum W F, Barth N, Coners H, Englaro P, Juul A, Ziegler A, Warnke A, Rascher W, Remschmidt H. Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration. Mol Psychiatry. 1997; 2 330-334
20 Ahima R S, Flier J S. Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000; 11 327-332
21 Farooqi I S. Leptin and the onset of puberty: insights from rodent and human genetics. Semin Reprod Med. 2002; 20 139-144
22 Ahima R S, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier J S. Role of leptin in the neuroendocrine response to fasting. Nature. 1996; 382 250-252
23 Bennett B D, Solar G P, Yuan J Q, Mathias J, Thomas G R, Matthews W. A role for leptin and its cognate receptor in hematopoiesis. Curr Biol. 1996; 6 1170-1180
24 Faggioni R, Feingold K R, Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J. 2001; 15 2565-2571
25 Faggioni R, Moser A, Feingold K R, Grunfeld C. Reduced leptin levels in starvation increase susceptibility to endotoxic shock. Am J Pathol. 2000; 156 1781-1787
26 Vande B erg, Malghem J, Devuyst O, Maldague B E, Lambert M J. Anorexia nervosa: correlation between MR appearance of bone marrow and severity of disease. Radiology. 1994; 193 859-864
27 Vaisman N, Barak Y, Hahn T, Karov Y, Malach L, Barak V. Defective in vitro granulopoiesis in patients with anorexia nervosa. Pediatr Res. 1996; 40 108-111
28 Nova E, Gomez-Martinez S, Morande G, Marcos A. Cytokine production by blood mononuclear cells from in-patients with anorexia nervosa. Br J Nutr. 2002; 88 183-188
29 Reseland J, Gordeladze J. Role of leptin in bone growth: central player or peripheral supporter?. FEBS Lett. 2002; 528 540
30 Goldstone A P, Howard J K, Lord G M, Ghatei M A, Gardiner J V, Wang Z L, Wang R M, Girgis S I, Bailey C J, Bloom S R. Leptin prevents the fall in plasma osteocalcin during starvation in male mice. Biochem Biophys Res Commun. 2002; 295 475-481
31 Berg A H, Combs T P, Scherer P E. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. 2002; 13 84-89
32 Tsao T S, Lodish H F, Fruebis J. ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol. 2002; 440 213-221
33 Stefan N, Stumvoll M. Adiponectin - its role in metabolism and beyond. Horm Metab Res. 2002; 34 469-474
34 Fruebis J, Tsao T S, Javorschi S, Ebbets-Reed D, Erickson M R, Yen F T, Bihain B E, Lodish H F. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA. 2001; 98 2005-2010
35 Berg A H, Combs T P, Du X, Brownlee M, Scherer P E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001; 7 947-953
36 Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman M L, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001; 7 941-946
37 Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn B B, Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002; 8 1288-1295
38 Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999; 100 2473-2476
39 Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froguel P, Nagai R, Kimura S, Kadowaki T, Noda T. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002; 277 25 863-25 866
40 Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Tenner A J, Tomiyama Y, Matsuzawa Y. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the function of macrophages. Blood. 2000; 96 1723-1732
41 Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257 79-83
42 Haque W A, Shimomura I, Matsuzawa Y, Garg A. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab. 2002; 87 2395
43 Delporte M L, Brichard S M, Hermans M P, Beguin C, Lambert M. Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf). 2003; 58 22-29
44 Yang W S, Lee W J, Funahashi T, Tanaka S, Matsuzawa Y, Chao C L, Chen C L, Tai T Y, Chuang L M. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001; 86 3815-3819
45 Halleux C M, Takahashi M, Delporte M L, Detry R, Funahashi T, Matsuzawa Y, Brichard S M. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun. 2001; 288 1102-1107
46 Zuniga-Guajardo S, Garfinkel P E, Zinman B. Changes in insulin sensitivity and clearance in anorexia nervosa. Metabolism. 1986; 35 1096-1100
47 Fukushima M, Nakai Y, Taniguchi A, Imura H, Nagata I, Tokuyama K. Insulin sensitivity, insulin secretion, and glucose effectiveness in anorexia nervosa: a minimal model analysis. Metabolism. 1993; 42 1164-1168
48 Hermans M P, Lambert M J. HOMA-modelling of insulin sensitivity and beta-cell function in anorexia nervosa. European Eating Disorders Review. 2002; 10 41-50
49 Bogan J S, Lodish H F. Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP30 and GLUT4. J Cell Biol. 1999; 146 609-620
50 Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 2001; 50 2094-2099
51 Yang W S, Jeng C Y, Wu T J, Tanaka S, Funahashi T, Matsuzawa Y, Wang J P, Chen C L, Tai T Y, Chuang L M. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care. 2002; 25 376-380
52 Warren M P. 1995 Anorexia nervosa. In: Endocrinology. DeGroot LJ (Ed) Philadelphia; W. B. Saunders 2679-2691
53 Urwin R E, Bennetts B, Wilcken B, Lampropoulos B, Beumont P, Clarke S, Russell J, Tanner S, Nunn K P. Anorexia nervosa (restrictive subtype) is associated with a polymorphism in the novel norepinephrine transporter gene promoter polymorphic region. Mol Psychiatry. 2002; 7 652-657
54 Delporte M L, Funahashi T, Takahashi M, Matsuzawa Y, Brichard S M. Pre- and post-translational negative effect of beta-adrenoceptor agonists on adiponectin secretion: in vitro and in vivo studies. Biochem J. 2002; 367 677-685
55 Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett. 2001; 507 142-146
56 Kappes A, Loffler G. Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes. Horm Metab Res. 2000; 32 548-554
57 Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, Paschke R. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications. 2003; 301 1045-1050
58 Corcos M, Guilbaud O, Paterniti S, Moussa M, Chambry J, Chaouat G, Consoli S M, Jeammet P. Involvement of cytokines in eating disorders: a critical review of the human literature. Psychoneuroendocrinology. 2003; 28 229-249
59 Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, Uchida S, Ito Y, Takakuwa K, Matsui J, Takata M, Eto K, Terauchi Y, Komeda K, Tsunoda M, Murakami K, Ohnishi Y, Naitoh T, Yamamura K, Ueyama Y, Froguel P, Kimura S, Nagai R, Kadowaki T. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem. 2003; 278 2461-2468
60 Yokota T, Meka C S, Medina K L, Igarashi H, Comp P C, Takahashi M, Nishida M, Oritani K, Miyagawa J, Funahashi T, Tomiyama Y, Matsuzawa Y, Kincade P W. Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J Clin Invest. 2002; 109 1303-1310
61 Steppan C M, Lazar M A. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab. 2002; 13 18-23
62 Steppan C M, Bailey S T, Bhat S, Brown E J, Banerjee R R, Wright C M, Patel H R, Ahima R S, Lazar M A. The hormone resistin links obesity to diabetes. Nature. 2001; 409 307-312
63 Ghosh S, Singh A K, Aruna B, Mukhopadhyay S, Ehtesham N Z. The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications. Gene. 2003; 305 27-34
64 Savage D B, Sewter C P, Klenk E S, Segal D G, Vidal-Puig A, Considine R V, O"Rahilly S. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes. 2001; 50 2199-2202
65 Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun. 2001; 285 561-564
66 Fain J N, Cheema P S, Bahouth S W, Lloyd H M. Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun. 2003; 300 674-678
67 Janke J, Engeli S, Gorzelniak K, Luft F C, Sharma A M. Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res. 2002; 10 1-5
68 McTernan P G, McTernan C L, Chetty R, Jenner K, Fisher F M, Lauer M N, Crocker J, Barnett A H, Kumar S. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab. 2002; 87 2407
69 Morash B A, Willkinson D, Ur E, Wilkinson M. Resistin expression and regulation in mouse pituitary. FEBS Lett. 2002; 526 26-30
70 Kim K H, Lee K, Moon Y S, Sul H S. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem. 2001; 276 11 252-11 256
71 Nakai Y, Hamagaki S, Takagi R, Taniguchi A, Kurimoto F. Plasma concentrations of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in patients with anorexia nervosa. J Clin Endocrinol Metab. 1999; 84 1226-1228
72 Holden R J, Pakula I S. Tumor necrosis factor-alpha: is there a continuum of liability between stress, anxiety states and anorexia nervosa?. Med Hypotheses. 1999; 52 155-162
73 Raymond N C, Dysken M, Bettin K, Eckert E D, Crow S J, Markus K, Pomeroy C. Cytokine production in patients with anorexia nervosa, bulimia nervosa, and obesity. Int J Eat Disord. 2000; 28 293-302
74 Brambilla F, Monti D, Franceschi C. Plasma concentrations of interleukin-1-beta, interleukin-6 and tumor necrosis factor-alpha, and of their soluble receptors and receptor antagonist in anorexia nervosa. Psychiatry Res. 2001; 103 107-114

S. M. Brichard

Unité d'Endocrinologie et Métabolisme

UCL 5530 Av. Hippocrate, 55 · 1200 Brussels · Belgium ·

Phone: +32-2-7645530

Fax: +32-2-7645532

Email: brichard@endo.ucl.ac.be